Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Myrbetriq™ (Mirabegron) to Reduce Pain and Discomfort Following Ureteral Stent Placement

NCT02462837 is registered in ClinicalTrials.gov with Southern Illinois University as lead sponsor.

NCT NCT02462837
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02462837 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Myrbetriq™ (Mirabegron) to Reduce Pain and Discomfort Following Ureteral Stent Placement
Lead sponsor
Southern Illinois University
Phase
Phase 2
Overall status
Terminated
Start date
May 31, 2015
Completion date
January 30, 2019
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lower urinary tract symptoms, pain, urinary bladder, overactive